- Home
- BAH vs BRKR Comparison
BAH vs BRKR Comparison
Compare BAH & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAH | BRKR |
|---|---|---|
| Founded | 1914 | 1960 |
| Country | United States | United States |
| Employees | 31500 | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.0B |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BAH | BRKR |
|---|---|---|
| Price | $73.83 | $56.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $97.00 | $48.54 |
| AVG Volume (30 Days) | 1.9M | ★ 2.4M |
| Earning Date | 05-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.09% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $11,217,000,000.00 | $1,895,600,000.00 |
| Revenue This Year | N/A | $6.30 |
| Revenue Next Year | $2.14 | $3.81 |
| P/E Ratio | $46.15 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $59.50 | $28.53 |
| 52 Week High | $111.20 | $65.30 |
Technical Indicators
Market Signals| Indicator | BAH | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 46.32 |
| Support Level | $68.84 | $54.54 |
| Resistance Level | $76.20 | $56.22 |
| Average True Range (ATR) | 2.55 | 2.38 |
| MACD | -0.33 | -0.00 |
| Stochastic Oscillator | 38.50 | 49.12 |
Price Performance
Historical ComparisonAbout BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.